Risk indicators of metabolic syndrome in young adults: A preliminary investigation on the influence of tobacco smoke exposure and gender

Heart and Lung: Journal of Acute and Critical Care

Volumn 35, Issue 2, 2006, Pages 119-129

  Corwin, Elizabeth J ^a,c   McCoy, Colleen S ^b   Whetzel, Courtney A ^b   Ceballos, Rachel M ^b   Klein, Laura Cousino ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; GLYCOSYLATED ALBUMIN; HOMOCYSTEINE; INTERLEUKIN 10; INTERLEUKIN 1BETA; LEPTIN; TOBACCO SMOKE;

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; MALE; METABOLIC DISORDER; METABOLIC SYNDROME X; METABOLISM; PILOT STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SEX ROLE; SMOKING; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; BLOOD PRESSURE; COMORBIDITY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; PILOT PROJECTS; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; SMOKING;

EID: 33644912881     PISSN: 01479563     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2005.09.003     Document Type: Article

References (90)

1. World Health Organization Definition, diagnosis, and classification of diabetes mellitus and its complications, part 1 Diagnosis and classification of diabetes mellitus Report of a WHO Consultation 1999
2. E.S. Ford, W.H. Giles, W.H. Dietz Prevalence of the metabolic syndrome among US adults findings from the third National Health and Nutrition Examination Survey J Am Med Assoc 287 2002 356 359
3. E. Eschwege The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes aetiological factors in the development of CV complications Diabetes Metab 29 2003 6S19 6S27
4. G.M. Reaven Hemostatic abnormalities associated with obesity and the metabolic syndrome J Thromb Haemost 3 2005 1074 1075
5. S. Bo, L. Gentile, G. Ciccone, C. Baldi, L. Benini, F. Dusio The metabolic syndrome and high C-reactive protein prevalence and differences by sex in a southern-European population-based cohort Diabetes Metab Res Rev 2005 May online.
6. E.S. Ford, U.A. Ajani, A.H. Mokdad The metabolic syndrome and concentration of C-reactive protein among U.S. youth Diabetes Care 28 2005 878 881
7. A.J. Hanley, A. Festa, R.B. D'Agostino Jr, L.E. Wagenknecht, P.J. Savage, R.P. Tracy Metabolic and inflammation variable clusters and prediction of type 2 diabetes factor analysis using directly measured insulin sensitivity Diabetes 53 2004 1173 1181
8. S. Malik, N.D. Wong, S. Franklin, J. Pio, C. Fairchild, R. Chen Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein Diabetes Care 28 2005 690 693
9. P. Muntner, J. He, J. Chen, V. Fonseca, P.K. Whelton Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome analysis of the Third National Health and Nutrition Examination Survey (NHANES III) Ann Epidemiol 14 2004 686 695
10. J.C. Pickup, M.A. Crook Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41 1998 1241 1248
11. N. Rifai High-sensitivity C-reactive protein a useful marker for cardiovascular disease risk prediction and the metabolic syndrome Clin Chem 51 2005 504 505
12. M.K. Rutter, J.B. Meigs, L.M. Sullivan, R.B. D'Agostino Sr, P.W. Wilson C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study Circulation 110 2004 380 385
13. K. Esposito, A. Pontillo, F. Giugliano, G. Giugliano, R. Marfella, G. Nicoletti Association of low interleukin-10 levels with the metabolic syndrome in obese women J Clin Endocrinol Metab 88 2003 1055 1058
14. E.S. van Exel, J. Gussekloo, A.J. de Craen, M. Frolich, A. Bootsma-Van Der Wiel, R.G. Westendorp Leiden 85 Plus Study Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes the Leiden 85-Plus Study Diabetes 51 2002 1088 1092
15. S. Devaraj, D.Y. Xu, I. Jialal C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells implications for the metabolic syndrome and atherothrombosis Circulation 107 2003 398 404
16. M.P. Cohen, R.S. Clements Measuring glycated proteins clinical and methodological aspects Diabetes Technol Ther 1 1999 57 70
17. S.M. Echwald, J.O. Clausen, T. Hansen, S.A. Urhammer, L. Hansen, B. Dinesen Analysis of the relationship between fasting serum leptin levels and estimates of beta-cell function and insulin sensitivity in a population sample of 380 healthy young Caucasians Eur J Endocrinol 140 1999 180 185
18. M. Valle, R. Martos, F. Gascon, R. Canete, M.A. Zafra, R. Morales Log-grade systemic inflammation, hypoadiponectinemia and a high concentration of leptin are present in very young obese children, and correlate with metabolic syndrome Diabetes Metab 31 2005 55 62
19. R.H. Unger Lipid overload and overflow metabolic trauma and the metabolic syndrome Trends Endocrinol Metab 14 2003 398 403
20. M.R. Malinow, A.G. Bostom, R.M. Krauss Homocysteine, diet, and cardiovascular diseases Circulation 99 1999 178 182
21. J.B. Meigs, P.F. Jacques, J. Selhub, D.E. Singer, D.M. Nathan, N. Rifai Framingham Offspring Study. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study Diabetes Care 24 2001 1403 1410
22. The American College of Endocrinology Position statement on the insulin resistance syndrome Endocr Pract 9 2003 240 252
23. S.Y. Chuang, C.H. Chen, P. Chou Prevalence of metabolic syndrome in a large health check-up population in Taiwan J Chin Med Assoc 67 2004 611 620
24. C. Geslain-Biquez, S. Vol, J. Tichet, A. Caradec, A. D'Hour, B. Balkau D.E.S.I.R. Study Group The metabolic syndrome in smokers. The D.E.S.I.R. study Diabetes Metab 29 2003 226 234
25. A. Onat, G. Hergenc, I. Keles, Y. Dogan, S. Turkmen, V. Sansoy Sex difference in development of diabetes and cardiovascular disease on the way from obesity and metabolic syndrome Metabolism 54 2005 800 808
26. R. Villegas, I.J. Perry, D. Creagh, R. Hinchion, D. O'Halloran Prevalence of the metabolic syndrome in middle-aged men and women Diabetes Care 26 2003 3198 3199
27. R. Lichnovska, S. Gwozdziewiczova, J. Hrebicek Gender differences in factors influencing insulin resistance in elderly hyperlipemic non-diabetic subjects Cardiovasc Diabetol 1 2002 4
28. B. Mittendorfer Insulin resistance sex matters Curr Opin Clin Nutr Metab Care 8 2005 367 372
29. A. Dzien, C. Dzien-Bischinger, F. Hoppichler, M. Lechleitner The metabolic syndrome as a link between smoking and cardiovascular disease Diabetes Obes Metab 6 2004 127 132
30. Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, S.B. Heymsfield The metabolic syndrome prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 2003 427 436
31. B. Eliasson, N. Mero, M.R. Taskinen, U. Smith The insulin resistance syndrome and postprandial lipid intolerance in smokers Atherosclerosis 129 1997 79 88
32. B. Fagerberg, L. Bokemark, J. Hulthe The metabolic syndrome, smoking, and antibodies to oxidized LDL in 58-year-old clinically healthy men Nutr Metab Cardiovasc Dis 11 2001 227 235
33. N.L. Benowitz Cigarette smoking and cardiovascular disease pathophysiology and implications for treatment Prog Cardiovasc Dis 46 2003 91 111
34. P.E. Cryer, M.W. Haymond, J.V. Santiago, S.D. Shah Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events N Engl J Med 295 1976 573 577
35. G.D. Friedman, A.L. Klatsky, A.B. Siegelaub Alcohol, tobacco, and hypertension Hypertension 4 5 Pt 2 1982 43 50
36. N.L. Benowitz, D.S. Sharp Inverse relation between serum concentration and blood pressure in cigarette smokers Circulation 80 1989 1309 1312
37. US Department of Health and Human Services. The health consequences of smoking: A report of the surgeon general. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
38. S. Attvall, J. Fowelin, I. Lager, H. Von Schenck, U. Smith Smoking induces insulin resistance-a potential link with the insulin resistance syndrome J Intern Med 233 1993 327 332
39. F.S. Facchini, C.B. Hollenbeck, J. Jeppesen, Y.D. Chen, G.M. Reaven Insulin resistance and cigarette smoking Lancet 339 1992 1128 1130
40. T. Ronnemaa, E.M. Ronnemaa, P. Puukka, K. Pyorala, M. Laakso Smoking is independently associated with high plasma insulin levels in non-diabetic men Diabetes Care 19 1996 1229 1232
41. L.A. Sargeant, K.T. Khaw, S. Bingham, N.E. Day, R.N. Luben, S. Oakes Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer Int J Epidemiol 30 2001 547 554
42. I.F. Godsland, F. Leyva, C. Walton, M. Worthington, J.C. Stevenson Associations of smoking, alcohol and physical activity with risk factors for coronary heart disease and diabetes in the first follow-up cohort of the Heart Disease and Diabetes Risk Indicators in a Screened Cohort study (HDDRISC-1) J Intern Med 244 1998 33 41
43. L. Henkin, D. Zaccaro, S. Haffner, A. Karter, M. Rewers, P. Sholinsky Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity the Insulin Resistance Atherosclerosis Study Ann Epidemiol 9 1999 290 296
44. R. Villegas, D. Creagh, R. Hinchion, D. O'Halloran, I.J. Perry Prevalence and lifestyle determinants of the metabolic syndrome Ir Med J 97 2004 300 303
45. N.J. Wareham, E.M. Ness, C.D. Byrne, B.D. Cox, N.E. Day, C.N. Hales Cigarette smoking is not associated with hyperinsulinemia evidence against a causal relationship between smoking and insulin resistance Metabolism 45 1996 1551 1556
46. W. Koenig, M. Sund, M. Frohlich, H.G. Fischer, H. Lowel, A. Doring C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992 Circulation 99 1999 237 242
47. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
48. J. Danesh, J.G. Wheeler, G.M. Hirschfield, S. Eda, G. Eiriksdottir, A. Rumley C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease N Engl J Med 350 2004 1387 1397
49. M.A. Mendall, P. Patel, L. Ballam, D. Strachan, T.C. Northfield C-Reactive protein and its relation to cardiovascular risk factors a population based cross sectional study BMJ 312 1996 1061 1065
50. R.P. Tracy, B.M. Psaty, E. Macy, E.G. Bovill, M. Cushman, E.S. Cornell Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in health elderly subjects Arterioscler Thromb Vasc Biol 17 1997 2167 2176
51. K. Wallenfeldt, J. Hulthe, L. Bokemark, J. Wikstrand, B. Fagerberg Carotid and femoral atherosclerosis, cardiovascular risk factors and C-reactive protein in relation to smokeless tobacco use or smoking in 58-year old women J Intern Med 250 2001 492 501
52. F. Bazzoni, B. Beutler The tumor necrosis factor ligand and receptor families N Engl J Med 334 1996 1717 1725
53. G.P. Brown, G.K. Iwamoto, M.M. Monick, G.W. Hunninghake Cigarette smoking decreases interleukin 1 release by human alveolar macrophages Am J Physiol 256 2 Pt 1 1989 C260 C264
54. M. Laan, S. Bozinovski, G.P. Anderson Cigarette smoke inhibits lipopolysaccharide-induced production of inflammatory cytokines by suppressing the activation of activated protein-1 bronchial epithelial cells J Immunol 173 2004 4164 4170
55. D.M. Soliman, H.L. Twigg 3rd Cigarette smoking decreases bioactive interleukin-6 secretion by alveolar macrophages Am J Physiol 263 4 Pt 1 1992 L471-L8
56. L. Ferrucci, A. Corsi, F. Lauretani, S. Bandinelli, B. Bartali, D.D. Taub The origins of a pro-inflammatory state Blood 30 2004 1 27
57. Youth Tobacco Cessation Collaborative National blueprint for action youth and young adult tobacco-use cessation 2000 Center for Advancement of Health Washington, DC
58. E.J. Corwin, L.C. Klein C-Reactive protein and depression in a sub-group of smokers during nicotine abstinence Hum Psychopharmacol 18 2003 1 9
59. E.J. Corwin, L.C. Klein, K. Rickelman Predictors of fatigue in healthy young adults Moderating effects of cigarette smoking and gender Biol Res Nurs 3 2002 222 233
60. L.C. Klein, E.J. Corwin, R. Ceballos Leptin, hunger, and body weight influence of gender, tobacco smoking, and smoking abstinence Addict Behav 29 2004 921 927
61. T.F. Heatherton, L.T. Kozlowski, R.C. Frecker, K.-O. Fagerstrom The Fagerstrom Test for Nicotine Dependence a revision of the Fagerstrom Tolerance Questionnaire Addiction 86 1991 1119 1127
62. L.T. Kozlowski, C.Q. Porter, C.T. Orleans, M.A. Pope, T. Heatherton Predicting smoking cessation with self-reported measures of nicotine dependence FTQ, FTND, and HSI Drug Alcohol Depend 34 1994 211 216
63. P. O'Hara, S.A. Portser, B.P. Anderson The influence of menstrual cycle changes on the tobacco withdrawal syndrome in women Addict Behav 14 1989 595 600
64. K.A. Perkins, E. Donny, A.R. Caggiula Sex differences in nicotine effects and self-administration review of human and animal evidence Nicotine Tob Res 1 1999 301 315
65. K.A. Perkins, M. Levine, M. Marcus, S. Shiffman, D. D'Amico, A. Miller Tobacco withdrawal in women and menstrual cycle phase J Consult Clin Psychol 68 2000 176 180
66. US Department of Health and Human Services The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) 2004 National Institutes of Health, National Heart, Lung, and Blood Institute Washington, DC
67. US Department of Health and Human Services Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults 1998 National Institutes of Health, National Heart, Lung, and Blood Institute Washington, DC
68. US Department of Health and Human Services 3rd Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002 National Institutes of Health, National Heart, Lung, and Blood Institute Washington, DC
69. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon III, M. Criqui Markers of inflammation and cardiovascular disease. A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
70. M.R. Malinow, A.G. Bostom, R.M. Krauss Homocysteine, diet, and cardiovascular diseases a statement for healthcare professionals from the Nutrition Committee, American Heart Association Circulation 99 1999 178 182
71. B. Fletcher, C. Lamendola Insulin resistance syndrome J Cardiovasc Nurs 19 2004 339 345
72. G.M. Reaven Role of insulin resistance in human disease Diabetes 37 1988 1595 1607
73. J.M. Fernandez-Real, M. Vayreda, C. Richart, C. Gutierrez, M. Broch, J. Vendrell Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women J Clin Endocrinol Metab 86 2001 1154 1159
74. A. Yamamoto, H. Temba, H. Horibe, H. Mabuchi, Y. Saito, Y. Matsuzawa Research Group on Serum Lipid Survey 1990 in Japan Life style and cardiovascular risk factors in the Japanese population-from an epidemiological survey on serum lipid levels in Japan 1990 part 2 association of lipid parameters with hypertension J Atheroscler Thromb 10 2003 176 185
75. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
76. E. Hud, M.P. Cohen Evaluation and performance characteristics of a novel ELISA using monoclonal antibody to glycated albumin Clin Chim Acta 185 1989 157 164
77. N.E. Grunberg Nicotine as a psychoactive drug appetite regulation Psychopharmacol Bull 22 1986 875 881
78. M.L. Winkelstein, R.H. Feldman Psychosocial predictors of consumption of sweets following smoking cessation Res Nurs Health 16 1993 97 105
79. K.C. Huang, R.C. Lin, N. Kormas, L.T. Lee, C.Y. Chen, T.P. Gill Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents Int J Obes Relat Metab Disord 28 2004 470 475
80. J. Steinberger, L. Steffen, D.R. Jacobs Jr, A. Moran, C.P. Hong, A.R. Sinaiko Relation of leptin to insulin resistance syndrome in children Obes Res 11 2003 1124 1130
81. H. Baumann, K.K. Morella, D.W. White, M. Dembski, P.S. Bailon, H. Kim The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors Proc Nat Acad Sci U S A 93 1996 8374 8378
82. R. Ahima, S.Y. Osei Leptin and appetite control in lipodystrophy J Clin Endocrinol Metab 89 2004 4254 4257
83. S.M. Echwald Genetics of human obesity lessons from mouse models and candidate genes J Intern Med 245 1999 653 666
84. A. Festa, R. D'Agostino Jr, G. Howard, L. Mykkanen, R.P. Tracy, S.M. Haffner Chronic subclinical inflammation as part of the insulin resistance syndrome the Insulin Resistance Atherosclerosis Study (IRAS) Circulation 102 2000 42 47
85. E.S. Ford The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count findings from the Third National Health and Nutrition Examination Survey Atherosclerosis 168 2003 351 358
86. K. Tamakoshi, H. Yatsuya, T. Kondo, Y. Hori, M. Ishikawa, H. Zhang The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state Int J Obes Relat Metab Disord 27 2003 443 449
87. M. Matsubara, K. Namioka, S. Katayose Decreased plasma adiponectin concentrations in women with low-grade C-reactive protein elevation Eur J Endocrinol 148 2003 657 662
88. B.G. Gabrielsson, J.M. Johansson, M. Lonn, M. Jernas, T. Olbers, M. Peltonen High expression of complement components in omental adipose tissue in obese men Obes Res 11 2003 699 708
89. B. Zahorska-Markiewicz, J. Janowska, M. Olszanecka-Glinianowicz, A. Zurakowski Serum concentrations of TNF-alpha and soluble TNF-alpha receptors in obesity Int J Obes Relat Metab Disord 24 2000 1392 1395
90. M.I. Schmidt, B.B. Duncan Diabesity an inflammatory metabolic condition Clin Chem Lab Med 41 2003 1120 1130